Skip to main content
OpenTrials

Clinical trial condition

Subcutaneous Emphysema

Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.

97 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Subcutaneous Emphysema trial results

Completed

Respreeza® Self-administration and Learning Program (AmAREtTI Study)

NCT04262284

Conditions
Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • CHU Angers Angers, France
  • CHU Bordeaux - Hôpital Haut-Lévèque Bordeaux, France
  • CHU Grenoble-Alpes Grenoble, France
  • CHU Lille Lille, France
View Trial Details
Completed

Study of DCR-A1AT in Healthy Adult Volunteers

NCT04174118

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Auckland Clinical Studies Grafton, Auckland, New Zealand
  • Clinical Trial Consultants AB Uppsala, Sweden
View Trial Details
Completed

Long-Term Follow-up Study of ADVM-043

NCT03804021

Conditions
Alpha-1 Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details
Completed

FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)

NCT02922751

Conditions
Abnormalities, Multiple, Alagille Syndrome, Alpha1 Anti-Trypsin Deficiency, +26 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California at San Francisco (UCSF) San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta (Emory University) Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency

NCT03679598

Conditions
Alpha-1 Antitrypsin Deficiency (AATD), Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
Locations
  • The University of Alabama at Birmingham Lung Health Center Birmingham, Alabama, United States
  • UCLA Los Angeles, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Columbia University New York, United States
View Trial Details
Completed

A Phase 1, First-in-human Study of VX-668

NCT05727800

Conditions
Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Celerion - Tempe Tempe, Arizona, United States
  • University of Florida Gainesville, Florida, United States
  • Central Florida Pulmonary Group, P.A. Orlando, Florida, United States
  • ICON Lenexa Lenexa, Kansas, United States
View Trial Details
Completed

A Phase 1, First-in-human Study of VX-634

NCT05579431

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Celerion - Tempe Tempe, Arizona, United States
  • University of Florida Gainesville, Florida, United States
  • Central Florida Pulmonary Group, P.A. Orlando, Florida, United States
  • ICON Lenexa Lenexa, Kansas, United States
View Trial Details

Related conditions